On Jan. 26, 2021, Eli Lilly announced that bamlanivimab (LY-CoV555) 2800 mg and etesevimab (LY-CoV016) 2800 mg together…
On Jan. 26, 2021, Regeneron announced positive initial results from an ongoing Phase 3 clinical trial evaluating REGEN-COV…
On Jan. 26, 2021, BioReference Laboratories, an OPKO Health company, announced COVID-19 testing agreements for players and officials,…
On Jan. 25, 2021, Merck announced that the company had discontinued development of its SARS-CoV-2/COVID-19 vaccine candidates, V590…
On Jan. 25, 2021, Medigen Vaccine Biologics and Dynavax Technologies announced that the first participant had been dosed…
On Jan. 25, 2021, the National Institutes of Health (NIH) announced that in large clinical trial conducted worldwide,…
On Jan. 25, 2021, scientists at the University of Oxford reported that after reviewing interim analyses of both…
On Jan. 25, 2021, Mateon Therapeutics announced that it was launching its mobile app, ARTIHealthTM, for respiratory health…
On Jan. 25, 2021, Emergent BioSolutions and Humanigen announced a contract development and manufacturing (CDMO) services agreement to…
On Jan. 25, 2021, Nirmidas Biotech announced its second FDA Emergency Use Authorization (EUA) for their COVID-19 rapid…
On Jan. 25, 2021, Moderna announced results from in vitro neutralization studies of sera from individuals vaccinated with…
On Jan. 25, 2021, BD (Becton, Dickinson) announced the publication of a peer-reviewed study that showed BD’s antigen…
On Jan. 22, 2021, the NIH announced that in large clinical trial conducted worldwide, full dose anti-coagulation (blood…
On Jan. 22, 2021, COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for…
On Jan. 22, 2021, Humanigen announced an expansion to the Cooperative Research and Development Agreement (CRADA) that the…
On Jan. 22, 2021, Novavax announced that it had finalized an agreement with the Government of Canada to…
On Jan. 22, 2021, Pfizer and BioNTech announced an advance purchase agreement with COVAX for up to 40…
On Jan. 21, 2021, the U.S. Department of Defense (DOD) recommended that adults ages 75 and older should…
On Jan. 21, 2021, Eli Lilly announced that bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19…
On Jan. 21, 2021, Moderna announced that the first participant has been dosed in the Phase 1/2 study…
On Jan. 21, 2021, Penn Medicine reported that patients with inactive cancer and not currently undergoing treatments also…
On Jan. 21, 2021, XBiotech announced that its COVID-19 candidate True Humanï¾™ antibody therapy may also be used…
On Jan. 19, 2021, the Northern Arizona University and TGen, an affiliate of City of Hope, announced results…
On Jan. 19, 2021, ImmunityBio announced it had received authorization from the South Africa Health Products Regulatory Authority…
On Jan. 19, 2021, Cue Health announced that its molecular, point-of-care COVID-19 Tests were being distributed to five…
On Jan. 19, 2021, Heat Biologics announced it had transferred its gp96-based COVID-19 vaccine cell line (“ZVX-60”) to…
On Jan. 19, 2021, Pfizer and BioNTech announced that results from an in vitro study that provided additional…
On Jan. 18, 2021, Quest Diagnostics announced that it has entered into an agreement with the Centers for…
On Jan. 15, 2021, Oxford University announced that on advice of the independent Data Monitoring Committee (DMC), recruitment…
On Jan. 15, 2021, scientists at Washington University School of Medicine in St. Louis announced that that a…